Home > Products > CD3 & CD79B
> Recombinant Anti-CD3 x Anti-CD79B Bispecific Antibody (scIgG)
Recombinant Anti-CD3 x Anti-CD79B Bispecific Antibody (scIgG) (CAT#: SCIGG-070)
Recombinant Anti-CD3 x Anti-CD79B Bispecific Antibody (scIgG) is designed to be expressed as two chains, each chain has the same units with their parental IgG antibodies, anti-CD3 and anti-CD79B IgGs. The two chains form heterodimer via Fc KIH technology. This BsAb can retarget T cells to tumor cells. It is designed for the research of Chronic lymphocytic leukemia (CLL); Non-Hodgkin's lymphoma (NHL); Diffuse large B cell lymphoma (DLBCL) therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD3 x Anti-CD79B Bispecific Antibody (scIgG) (SCIGG-070). Click the button below to contact us or submit your feedback about this product.